Based on SEC filing data. A company founded in 2015 and based in London raised $21.4M in a Series B equity round. The company operates as an alternative entity type in the UK market.
Get notified the moment Arix Bioscience plc files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.